4 IBD 50 Drugmakers Getting Lift From New Treatments

By | August 29, 2015

Scalper1 News

Volatility is the word of the day in the stock market, and drugmakers with strong growth prospects and proven long-term stability, such as IBD 50 member Valeant Pharmaceuticals (VRX), may be good stock watch list candidates. The IBD 50 spotlights the top performers among all U.S.-listed stocks, based on a combination of factors including sales and profit growth. Today’s roster includes four large, high-rated drugmakers: Valeant, Regeneron Scalper1 News

Scalper1 News